ENOUGH: Funding, Investors & Team (Oct 2026)
ENOUGH, a spin-off company from the University of Strathclyde, was created to advance and market groundbreaking patented technology that revolutionizes the cost-effectiveness of creating meat-free food product mycoprotein. This is achieved by incorporating the production process within existing bio-refinery operations that produce bio-ethanol and animal feed (DDGS), leading to the integrated manufacture of Food, Fuel, and Feed through fermentation.
ENOUGH has raised $43.6M across 1 funding round on record, the most recent a Series C of $43.6M announced in Aug 2023.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
ENOUGH Company Profile and Key Stats
Latest funding round on record: Aug 2023.
ENOUGH Funding Rounds
ENOUGH Founders and Leadership Team
No contact details are on record for this team yet.
ENOUGH Funding Compared to Other Biotechnology Startups
ENOUGH's latest round of $43.6M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ENOUGH in Biotechnology and Glasgow
Companies Similar to ENOUGH
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
ENOUGH Funding FAQs
What does ENOUGH do?
ENOUGH, a spin-off company from the University of Strathclyde, was created to advance and market groundbreaking patented technology that revolutionizes the cost-effectiveness of creating meat-free food product mycoprotein. This is achieved by incorporating the production process within existing bio-refinery operations that produce bio-ethanol and animal feed (DDGS), leading to the integrated manufacture of Food, Fuel, and Feed through fermentation.
How much funding has ENOUGH raised?
ENOUGH has raised $43.6M across 1 round on record. The most recent is a Series C of $43.6M announced in Aug 2023.
When did ENOUGH last raise funding?
ENOUGH's most recent funding round on record is a Series C of $43.6M, announced in Aug 2023.
Who founded ENOUGH?
FundedIQ lists Craig Johnston (Founder) at ENOUGH.
Where is ENOUGH headquartered?
ENOUGH is based in Glasgow, United Kingdom.
How many employees does ENOUGH have?
ENOUGH is in the 51-100 employee band.
How does ENOUGH's funding compare to other Biotechnology startups?
ENOUGH's latest round of $43.6M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's ENOUGH Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ENOUGH is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.